FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
758 letters match. Newest first.
-
DrugsCTK OTC Laboratories LLC formerly FMK LABS, Inc.
CTK OTC Laboratories, formerly FMK Labs, failed to investigate out-of-spec results and validate processes for OTC drugs, including sunscreens.
High risk -
DrugsRechon Life Science AB
FDA warns Swedish sterile drugmaker Rechon Life Science over aseptic technique, weak investigations, cleaning and facility problems.
High risk -
BiologicsAmy Lightner, MD
FDA warns sponsor-investigator Amy Lightner, MD over clinical trial violations, including dosing before eligibility tests and unreported serious adverse events.
High risk -
DrugsHuangshi Hygienic Material Medicine Co., Ltd.
Huangshi Hygienic Material Medicine released U.S. drugs without identity and strength testing and lacked stability data for labeled expiration dates.
High risk -
FoodUnited King Foods Private Limited
FDA warned United King Foods over serious low-acid canned food processing violations for Gulab Jamun exported to the U.S.
High risk -
DrugsAACE Pharmaceuticals, Inc.
AACE Pharmaceuticals distributed adulterated Lubricant PM Ointment made by CMO Brassica with CGMP violations and failed supplier qualification.
High risk -
FoodGolden Grains Bakery
FDA warns Golden Grains Bakery over repeated preventive-control failures for RTE Blender Bombs, including metal detection and Listeria risks.
High risk -
FoodBaldwin Richardson Foods Pennsauken, LLC
FDA warned Baldwin Richardson Foods Pennsauken of serious low-acid canned food violations after finding microbial growth and process-control failures in aseptic non-dairy beverages.
High risk -
AnimalFishMoxFishFlex/Simple Pet Health LLC
FDA warned Simple Pet Health (FishMoxFishFlex) that it sells unapproved, misbranded antibiotic drugs for fish and birds online.
High risk -
BiologicsSupreme Rejuvenation, LLC
FDA warned Supreme Rejuvenation that its exosome products are unapproved new drugs and unlicensed biological products.
High risk -
DrugsSarfez Pharmaceuticals, Inc.
FDA says Sarfez made false or misleading efficacy and risk claims for Soaanz (torsemide) in webpages, pamphlet, and exhibit panel.
High risk -
DrugsWuxi Medical Instrument Factory Co., Ltd.
FDA warns Wuxi Medical Instrument Factory over insanitary conditions and manufacturing failures for sterile drugs.
High risk -
FoodYeshua Bendito, C.A.
FDA says Yeshua Bendito's Venezuelan RTE crab meat in reduced oxygen packaging is adulterated due to serious seafood HACCP violations.
High risk -
DrugsExcelvision Fareva
Excelvision Fareva, a sterile drug manufacturer, was cited for inadequate mold/black-speck complaint investigations and aseptic contamination controls.
High risk -
DrugsNingbo Riway Industrial Co., Ltd.
Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.
High risk -
DrugsOSRX, Inc.
OSRX, a Montana compounding facility, made sterile ophthalmic drugs under insanitary conditions with quality and labeling failures.
High risk -
DrugsMentha & Allied Products Private Ltd.
FDA warns Mentha & Allied Products of CGMP failures that leave its APIs adulterated.
High risk -
DrugsShantou S.E.Z. Baojie Industry Co., Ltd.
FDA warns Shantou S.E.Z. Baojie Industry over inadequate CGMP and component testing for OTC drug products, leading to Import Alert 66-40.
High risk -
DrugsTaizhou Jingshang Cosmetics Technology Co., Ltd.
FDA warns Taizhou Jingshang Cosmetics Technology over current good manufacturing practice failures in over-the-counter drugs, including missing identity tests for high-risk ingredients.
High risk -
DrugsBioAsia Worldwide Sdn Bhd
FDA warned BioAsia Worldwide over current good manufacturing practice violations for OTC drugs.
High risk -
DrugsNana Barseghian, M.D.
FDA warns clinical investigator Nana Barseghian for enrolling high-body-mass-index subjects in drug trials despite protocol exclusion.
High risk -
DrugsAmazon.com, Inc.
Amazon sold unapproved numbing creams for tattoos and cosmetic procedures, FDA says.
High risk -
DrugsCosco International, Inc.
FDA warned Cosco International over nonprescription drug manufacturing failures and unapproved drug products.
High risk -
AnimalLivestock Nutrition Center
Livestock Nutrition Center made non-medicated animal feed contaminated with monensin, killing animals; FDA found preventive control failures.
High risk -
DevicesNoah Medical Corporation
FDA warns Noah Medical of San Jose, CA over quality system failures and missed injury reports for its Galaxy bronchoscopes.
High risk -
DevicesEpiCare Acquisitions, LLC
FDA warns EpiCare Acquisitions over unvalidated EpiCare-Zenith lasers and flawed complaint, corrective-action, record, training, and reporting procedures.
High risk -
DrugsAspen Biopharma Labs Private Limited
FDA warns Aspen Biopharma Labs over current good manufacturing practice failures in active ingredient manufacturing after U.S. recall.
High risk -
DevicesDexcom, Inc.
FDA warned Dexcom over quality-system and design-control failures for G6 and G7 glucose monitors, including an unapproved sensor component change.
High risk -
BiologicsMG Infusions
FDA warned MG Infusions it sells unlicensed fecal transplant products online without required approval.
High risk -
DrugsInternational Laboratories Corp
FDA warned International Laboratories Corp, a Thai drug manufacturer, over fabricated lab records and inadequate CGMP controls.
High risk -
DrugsShree Jaya Laboratories PVT. LTD.
FDA warned Shree Jaya Laboratories after an inspection found CGMP deviations in API and intermediate manufacturing, including dirty equipment and torn batch records.
High risk -
DrugsLinghai ZhanWang Biotechnology Co., Ltd
Linghai ZhanWang Biotechnology's OTC drugs, including antimicrobial wipes, fail manufacturing quality rules; FDA cites missing tests.
High risk -
AnimalElanco Animal Health
FDA says Elanco's Zenrelia promotional materials omit or misstate safety warnings and study results, misbranding the veterinary drug.
High risk -
DrugsGranules India Limited
FDA warned Granules India in Telangana, India, that its finished drugs are adulterated after inspectors found cross-contamination in air ducts, bird droppings and torn records.
High risk -
DrugsTKTX USA
FDA warned TKTX USA that its TKTX Numbing Creams are unapproved and misbranded drugs with lidocaine levels above OTC limits.
High risk -
DrugsZenzi Pharmaceutical Industries Pvt. Ltd.
Zenzi Pharmaceutical Industries refused FDA requests for records about prescription drugs made for the U.S. market.
High risk -
DrugsABR Laboratory LLC
FDA warned ABR Laboratory, a contract drug testing lab, that unverified microbial test methods and missed investigations made tested drugs adulterated.
High risk -
DrugsTyche Industries Ltd
FDA warned Tyche Industries over falsified records, dirty equipment, and untested raw materials at its API plant.
High risk -
DrugsJagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals cited for API CGMP and listing failures after Indian inspection, leading to US import alert.
High risk -
DrugsISOThrive, Inc.
ISOThrive ran two human studies of a supplement used as a drug without submitting a required IND.
High risk -
DrugsStrukmyer LLC dba Strukmyer Medical
Strukmyer Medical was cited for current good manufacturing practice violations after FDA found repeated microbial contamination in water used to make OTC drugs.
High risk -
DrugsShantou Kangjie Daily Chemical Industry Co., Ltd
FDA warns Shantou Kangjie over CGMP failures for OTC drugs, including untested ethanol and no quality unit.
High risk -
BiologicsBioStem Life Sciences
FDA says BioStem Life Sciences made unapproved umbilical cord and amniotic products with significant CGMP violations.
High risk -
DrugsGlobal Calcium Pvt. Limited
FDA cites Global Calcium API plant for falsified records, deleted files, facility leaks and incomplete impurity profiles; products on Import Alert 66-40.
High risk -
DrugsFagron Compounding Services, LLC dba Fagron Sterile Service
FDA warns Fagron Sterile Services about unsafe sterile drug production and labeling problems at its Wichita facility.
High risk -
BiologicsChara Biologics, Inc.
FDA warns Chara Biologics over unapproved, unlicensed CharaExo, CharaCore, CharaOmni.
High risk -
DrugsAtlanta Supersource, Inc.
Atlanta Supersource made OTC hand sanitizers on equipment shared with toxic industrial chemicals and lacked testing, FDA says.
High risk -
FoodDuong Ha Processing Trading Seafood Company Limited
FDA warns Vietnam seafood processor Duong Ha over HACCP failures for frozen scombrotoxin-forming fish.
High risk -
DevicesIntegra LifeSciences Corporation
FDA warned Integra LifeSciences over bacterial toxin test and sterilization failures at three medical device plants.
High risk -
DrugsIndoco Remedies Limited
FDA warned Indoco Remedies over manufacturing quality failures at its Goa plant, including unreliable microbial testing and aseptic processing deficiencies.
High risk